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Driven by interactions between lipids and proteins, biological membranes display lateral
heterogeneity that manifests itself in a mosaic of liquid-ordered (Lo) or raft, and
liquid-disordered (Ld) or non-raft domains with a wide range of different properties and
compositions. In giant plasma membrane vesicles and giant unilamellar vesicles, specific
binding of Cholera Toxin (CTxB) to GM1 glycolipids is a commonly used strategy to
label raft domains or Lo membrane environments. However, these studies often use
acyl-chain labeled bodipy-GM1 (bdGM1), whose headgroup accessibility andmembrane
order or phase partitioning may differ from those of GM1, rendering the interpretation of
CTxB binding data quite problematic. To unravel the molecular basis of CTxB binding
to GM1 and bdGM1, we explored the partitioning and the headgroup presentation
of these gangliosides in the Lo and Ld phases using atomistic molecular dynamics
simulations complemented by CTxB binding experiments. The conformation of both
GM1 and bdGM1 was shown to be largely similar in the Lo and Ld phases. However,
bdGM1 showed reduction in receptor availability when reconstituted into synthetic
bilayer mixtures, highlighting that membrane phase partitioning of the gangliosides plays
a considerable role in CTxB binding. Our results suggest that the CTxB binding is
predominately modulated by the partitioning of the receptor to an appropriate membrane
phase. Further, given that the Lo and Ld partitioning of bdGM1 differs from those of GM1,
usage of bdGM1 for studying GM1 behavior in cells can lead to invalid interpretation of
experimental data.
Keywords: GM1, ganglioside, cholera toxin, membrane domains, molecular dynamics simulations, model
membranes
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INTRODUCTION
Glycosphingolipids (GSLs) are important constituents of cell
membranes, participating in a wide range of biological processes
such as recognition of hormones, function of bacterial and
viral toxins, cell growth/differentiation, and cell-cell interaction
(Karlsson, 1989; Miljan and Bremer, 2002; Ewers et al., 2009).
The key to understanding GSL function is the conformational
behavior of GSL headgroups. Molecular dynamics (MD)
simulations and structural data for the GM1 headgroup-
lectin interactions have suggested GSL headgroups to undergo
differential conformational selection (Lingwood et al., 2011;
Blaum et al., 2016). Interestingly, GSLs are often referred to
as being “cryptic,” which stems from the observation that their
recognition is regulated by the physicochemical properties of the
proximal membrane environment, such as membrane fluidity
influenced by, e.g., cholesterol concentration and protein content
(Shichijo and Alving, 1985; Lampio et al., 1986; Stewart and
Boggs, 1993; Kiarash et al., 1994; Mahfoud et al., 2010; Sezgin
et al., 2012b). These findings suggest that the conformational
landscape of the GSL headgroup is subject to various physical
factors such as spatial and electrostatic effects imposed by the
headgroup’s chemical structure and its molecular interactions.
Differential ligand recognition of discrete pools of GSLs in
native membrane environments has also been suggested to
play an important role in triggering specific signaling pathways
(Haselhorst et al., 2001; Blaum et al., 2016). Therefore, it is
important to understand the molecular mechanism of how
membranes and their physicochemical properties modulate GSL
headgroup presentation and availability.
Among the many GSLs, GM1 (Figure 1A) is used as a default
lipid marker for the nanoscopic cholesterol/sphingomyelin
(Chol/SM) enriched, liquid-ordered (Lo) membrane domains
usually referred to as “membrane rafts,” opposing liquid-
disordered (Ld) environments (Harder et al., 1998; Bacia et al.,
2005; Ewers et al., 2009; Sezgin et al., 2012a,b). In cell membranes,
cell-derived giant plasma membrane vesicles (GPMVs), and
synthetic giant unilamellar vesicles (GUVs), GM1 detection by
fluorescently labeled Cholera Toxin (CTxB) is a well-established
tool for monitoring Lo membrane domains. Alternative and
more direct reporters of GM1 are fluorescent analogs such as the
acyl chain-bodipy labeled GM1 (bdGM1, Figure 1A). However,
these GM1 analogs are not identical to native GM1 in terms of
their biochemical and biophysical behavior, and it is not clear
whether the conformational distributions of GM1 and bdGM1
headgroups are alike, as they should be if bdGM1 were used to
consider CTxB binding with GM1. Further, bdGM1 is excluded
from Lo domains in GUVs, while it is equally distributed in
GPMVs (Sezgin et al., 2012a,b). Toxin binding, however, occurs
in both systems exclusively in the Ld phase, which gives rise to a
question of the importance of membrane phase in CTxB binding.
Given the importance of GM1-CTxB binding in initiation of
specific signaling pathways at cell surfaces, determination of the
principles guiding the binding of CTxB to GM1 and bdGM1 is
called for.
Here, we used extensive atomistic MD simulations supported
with CTxB binding experiments to investigate how the binding
of CTxB to its receptor (GM1, bdGM1) is modulated by the
receptor’s membrane phase partitioning. The results highlight
the importance of ganglioside partitioning in CTxB binding and
the great care needed in interpreting results based on the use of
labeled ganglioside receptors.
RESULTS
Atomistic Simulations Highlight Subtle
Differences between GM1 and bdGM1
Headgroup Conformations
CTxB is a pentameric protein with five GM1 binding sites
(Merritt et al., 1994). Therefore, geometrical compatibility
between CTxB and GM1 molecules in the plane of a membrane
is essential for efficient binding (Ewers et al., 2009). Given
this, any structural modifications or GM1 reorganization in
the membrane plane could compromise the binding. This
would likely take place if a fluorophore were attached to
GM1, which is the case with bdGM1, or if the state of liquid
ordering of the surrounding lipid matrix would change, which
is the case if CTxB binding would take place in Ld instead
of Lo. To explore the consequences of these scenarios, we
performed all-atom molecular dynamics (MD) simulations
on GM1 and bdGM1 (Figure 1A) in both Lo (N-stearoyl-D-
erythro-sphingosylphosphorylcholine/cholesterol (SSM/Chol))
and Ld (1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC))
membranes. Lo membranes were composed of ∼46 mol% Chol,
∼46mol% SSM, and∼8mol%GM1 (or bdGM1). Ldmembranes
were comprised of ∼92 mol% DOPC with about 8 mol% GM1
(or bdGM1). Both Lo and Ld membranes were studied both with
and without CTxB (see Table S1, see Supplementary Information
(SI)). The key microsecond-simulations were carried out in
three replicas. Details of the simulation models, simulations, and
experimental methods and materials are discussed in SI.
First we analyzed how the GM1 headgroups are localized and
oriented. We therefore calculated the mass density profiles of
atoms from the GM1 headgroup and its components subdivided
in thumb, forefinger, and wrist subunits (Figures 1B,C and
Figures S1, S2). No significant differences between the Lo and
Ld environments were observed in the localization of the GM1
headgroups for either GM1 or bdGM1, except for a minor
shift toward the membrane core for bdGM1 in the Lo phase
(Figure 1). This effect was strongest for the thumb and the
forefinger rings of the bdGM1 headgroup (Figure S2). The results
for the mass density profiles were confirmed by data for the
solvent accessible surface area (SASA), which is the molecule’s
surface area that is accessible to solvent (in this case, water) (for
the definition of SASA, see SI). SASA provides an estimate for
the exposure of the GM1 headgroup to the water phase above
the bilayer core and therefore indirectly indicates to what extent
the headgroup is oriented toward the water phase. Only for
bdGM1 a pronounced SASA change of ∼0.43 nm2 per molecule
between Ld and Lo was observed, indicating a higher exposure
of the bdGM1 headgroup in Ld (Figure 1D and Table S2). The
difference in SASA for bdGM1 was mainly caused by a change
in the orientation of the thumb region (Figure S3). Overall, these
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FIGURE 1 | Headgroup geometry of GM1 and bdGM1 in the Lo and Ld phases. (A) Snapshot of GM1 and bdGM1 taken from the atomistic MD simulations. (B)
Illustration of the vectors representing the different GM1 headgroup subunits. (C) Density profiles of atoms from GM1 headgroups in membranes that are in the Ld and
Lo phases (in systems 5–8, Table S1 without CTxB). Here, a value of zero in membrane depth corresponds to the bilayer center. The differences in the absolute
density values for the GM1 headgroups are attributed to the presence of cholesterol, which is significantly smaller than the other surrounding lipids, thus reducing the
dimensions of the simulation box in the Lo system. (D) Results for the solvent accessible surface area (SASA) calculated per molecule for GM1 and bdGM1
headgroups (see also Figure S3). In each graph, the results of three replicas are shown by means of gray transparent lines. (E) Angle distributions in Ld and Lo for the
different subunits of GM1 and bdGM1. The angle is defined with respect to the membrane normal, thus a value of zero corresponds to a situation where the vector
stands upright along membrane normal, and an angle of 90◦ describes a vector lying along the membrane surface. (D,E) are based on data with CTxB, but the results
have been computed from the leaflet not bound to CTxB.
observations may partially explain the preferential CTxB binding
of bdGM1 in the Ld phase of phase separated model membranes
(Sezgin et al., 2012b).
To quantitatively determine whether these differences stem
from altered headgroup conformations, we calculated the angles
between membrane normal and vectors of the respective GM1
headgroup components. Here, we found that for both GM1 and
bdGM1 the conformation of the headgroup is very similar—the
forefinger is tilted toward the membrane, while the thumb and
the wrist subunits are more exposed to water (Figure 1E and
Table S3)—largely regardless of the molecular structure and
membrane environment. However, while the overall changes
between the four systems are relatively small (Figure 1E and
Table S3), there are a few interesting features that may be
involved in the altered GM1-CTxB binding and thus need to be
highlighted. First, the bodipy label orients the ganglioside wrist
subunit toward the water phase by ∼5◦, and this result holds
in both lipid environments when compared to unlabeled GM1.
Second, if the bodipy marker is attached to GM1, the thumb
part of the GM1 headgroup is tilted slightly (by ∼3◦) toward the
water phase in Ld, but (by ∼2◦) toward the membrane in Lo,
which largely explains the difference observed in themass density
profile in the Lo phase (Figure 1C). The forefinger subunit of
bdGM1 is oriented slightly more toward the membrane than
the forefinger of GM1. In the case of bdGM1, this orientation
in favor of the membrane surface is larger in Ld than in Lo. In
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the case of GM1, the forefinger in Lo tilts to some extent more
toward the membrane surface than in Ld. These differences are
not substantial but anyhow evident. Themajority of the change in
the forefinger orientation is caused by the terminal sugar residue
(β-galactose; Figure S4, and Table S4).
The results in Figure 1E suggest that the conformation of
GM1 with respect to the membrane plane is not dependent
on cholesterol. Meanwhile, recent MD simulations on
POPC/cholesterol/GM1membranes (with a ratio of 75/20/5) and
experiments are in favor of the opposite view (Lingwood et al.,
2011). We therefore explored this matter by considering the
conformation of GM1 in a DOPC/cholesterol/GM1 membrane
with∼46mol%DOPC,∼46mol% cholesterol, and about 8mol%
GM1, where the relative amounts of these lipid types match those
used in the present Lo bilayers with SSM, cholesterol, and GM1.
The results (Figure S5) show that in the DOPC/cholesterol/GM1
membrane the headgroup of GM1 is strongly tilted against the
membrane, in agreement with ref. (Lingwood et al., 2011), the
tilt angle of the GM1 headgroup in this case being much larger
than in SSM/cholesterol/GM1 membranes. Clearly, the GM1
headgroup orients in a cholesterol-dependent manner, however
the significance of cholesterol depends on the lipid pool hosting
cholesterol.
The observed conformational differences prompted us to
follow the availability of the headgroup for ligand binding. We
therefore simulated the actual binding of CTxB to both GM1
and bdGM1 in Ld and Lo environments (snapshots taken from
simulations shown in Figure 2A). As Figure 2B illustrates, the
binding of CTxB to the membranes took place rapidly in about
20-100 ns. The number of hydrogen bonds established between
the protein and the respective GM1 molecules was used as a
correlate for the binding affinity (Figures 2B,C and Table S5).
For GM1, this analysis revealed a greater number of CTxB-GM1
hydrogen bonds in the Ld phase, suggesting a slight preference
for CTxB binding to the Ld phase (Figure 2C, and Tables S5).
For bdGM1, the effect was similar but quite a bit weaker. These
conclusions are supported by consideration of contacts between
CTxB and GM1 (or bdGM1), (Table S6), using 0.35 nm as the
maximum distance for a contact. This analysis revealed that the
number of GM1/bdGM1 bound to CTxB was 8.9 ± 0.7 (GM1
in Ld), 6.8 ± 1.0 (GM1 in Lo), 5.6 ± 1.4 (bdGM1 in Ld), and
6.9± 0.9 (bdGM1 in Lo).
Experiments Point to Differences in
Membrane Phase Partitioning
The high specificity of CTxB binding to GM1 is commonly used
to detect the presence of raft or Lo domains in cellular and
synthetic membranes, respectively. However, based on our MD
simulation data, slightly more efficient binding of CTxB to GM1
in the Ld environment is expected. One possible explanation for
the discrepancy is that CTxB would bind GM1 preferentially in
an Ld domain, but then the complex would move into an Lo
domain, as suggested previously (Bacia et al., 2005). To test this
possibility, we followed the binding of Alexa-labeled CTxB to
GM1-containing GUVs and GPMVs immediately after addition
of CTxB. In both model membranes, CTxB bound rapidly and
largely to the Lo phase without obvious initial binding to the Ld
phase (Figures 3A,B and Supplementary Movies 1, 2). Thus, it is
unlikely that the experimentally observed binding to the Lo phase
is a result of initial/stronger recognition of the GM1 molecules
in the Ld phase by CTxB and subsequent partitioning of the
GM1-CTxB complex into the Lo phase.
An alternative explanation for the observed discrepancy is
that CTxB binds its lipid receptor GM1 preferentially in Lo
FIGURE 2 | Simulation results gauging the dependence of GM1-CTxB binding on membrane environment in simulations of systems with CTxB. (A)
Snapshots of simulated membrane systems at 0 (left) and 500 ns (right) in Ld (upper) and Lo (lower) phases (Lo composition: 46 mol% Chol, 46 mol% SSM, and 8
mol% GM1 (or bdGM1); Ld composition: 92 mol% DOPC and 8 mol% GM1 (or bdGM1)). DOPC is depicted in brown, cholesterol in red, SSM in yellow, and GM1 in
orange. Water molecules are not shown for clarity. (B) Time course of the number of hydrogen bonds established between GM1 species and CTxB. Each case was
simulated three times. (C) Average number of hydrogen bonds (H bonds) established between GM1 species and CTxB between 300 and 1,000 ns. The error bar
represents the standard error.
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FIGURE 3 | Time-lapse confocal imaging of the equatorial plane of (A) phase separated GUVs (DOPC:SSM:Chol:GM1 = 40:40:20:0.1) and (B) phase
separated GPMVs prepared from RBL cells (labeled with the Ld marker Fast-DiI, red), following the addition (at time 0) and rapid binding of Alexa 488-labeled CTxB
(green) to GM1. Binding occurs right after CTxB addition in the Lo phase. Scale bar 10 µm. Experiments were done at 10◦C. Miscibility temperature for GPMVs is
around 15◦C.
domains, once coexisting Ld/Lo phases are available. In order
to selectively monitor CTxB binding to its lipid receptor in
pure Ld or Lo membrane only, we used synthetic liposomes
consisting of either DOPC (Ld) or SM/Chol (Lo) and 0.1
mol% of either GM1 or bdGM1. These liposomes were then
used as capture specimen in electrochemiluminescence ELISA
assays to quantitatively evaluate CTxB binding (Kolondra
et al., 2010; Lingwood et al., 2011). Equal GSL content in
liposomes was validated by thin-layer chromatography (TLC)
analysis (Figure S6). In all systems we observed similar
equilibrium binding affinities of ∼15 nM, independent of
lipid composition or GM1 acyl bodipy modification (Figure 4,
and Table 1). However, we observed obvious differences in
Bmax (maximum binding capacity) values. In Ld liposomes,
bdGM1 showed Bmax to decrease ∼20% compared to native
GM1. In Lo domains, the decrease was ∼35–40%. In our
experimental conditions this means that less CTxB were bound
to the bdGM1 vesicles than to those containing GM1. Since
in all the studied systems the GM1 amounts were similar,
the decreased Bmax values suggest that in the respective
systems, a number of bdGM1 molecules remain hidden from
CTxB. Although these observations are consistent with the
trends predicted by atomistic MD simulations (Figures 2B,C),
there is reason to keep in mind that the headgroup angle
distribution and SASA of GM1 and bdGM1 showed only slight
differences, and therefore the results suggest that other factors,
e.g., ganglioside oligomerization may be involved (Shi et al.,
2007).
Our simulations and experimental measurements document
that, although GM1 headgroup conformation is slightly
modulated by the surrounding lipid environment, it is not the
discriminating factor for the differences in CTxB binding to
GM1 and its fluorescent analog. CTxB binding to GM1 shows
a clear preference for the Lo phase in both GUVs and GPMVs
FIGURE 4 | Representative plot showing binding of Alexa 594-labeled
CTxB to liposomes containing 0.1mol % GM1 or bdGM1.
TABLE 1 | Results for characteristics of Alexa594-labeled CTxB binding to
liposomes containing 0.1 mol% GM1 or bdGM1 (n = 3).
CTxB-Alexa594 Kd [nM] Bmax
Ld+GM1 16.56 ± 6.11 97.95% ± 1.93
Lo+GM1 15.59 ± 5.80 100%
Ld+bdGM1 13.48 ± 5.34 79.76% ± 7.23
Lo+bdGM1 14.85 ± 4.06 63.76% ± 10.52
The Bmax was normalized to the highest value in each experiment.
(Figure 3), which in respect to slight headgroup conformation
changes and comparable CTxB binding affinities to these
molecules can only be explained by the enrichment of the GM1
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lipids in the ordered phases (Morrow et al., 1995; Simons and
Ikonen, 1997).
DISCUSSION AND CONCLUDING
REMARKS
Our atomistic MD simulation data confirmed that GM1
headgroup localization and geometry is sensitive to membrane
environment (Figures 1, 2). Surprisingly, the presence of the
bodipy-label at the acyl chain of GM1 caused a deeper
penetration of bdGM1 into the membrane in the Lo domains
(Figures 1C,E), demonstrated by decreased SASA and the
density distribution of the forefinger structure (Figures 1B–E
and Figures S2, S4, S5). The overall changes could thus
render the bdGM1 headgroup partially inaccessible to CTxB.
Our observations are consistent with previously reported
NMR analysis in synthetic membranes, which showed that
conformation and motional order of the complex ganglioside
headgroups is influenced by factors such as natural variation
in the glycolipid hydrocarbon chains, membrane fluidity,
temperature, or the presence of cholesterol (Barber et al., 1994;
Morrow et al., 1995; Singh et al., 1995). Interestingly, as presented
by our simulations, the observed changes in GM1 headgroup
conformation indicate a preference for CTxB binding to GM1
in the Ld environment rather than Lo (Figure 2). This result
is in line with previously published atomistic MD simulations
of GM1 in POPC or POPC/Chol membranes, which showed
that GM1 headgroup adopts a tilted conformation in the
presence of cholesterol, resulting in decreased recognition by
CTxB (Lingwood et al., 2011). However, the effect of membrane
phase on CTxB-GM1 interaction was weak in the present
simulations, and this lack of a strong effect was validated
experimentally by measuring binding of CTxB to synthetic
liposomes in various phases (Table 1 and Figure 4). The binding
data showed that the overall binding of CTxB to bdGM1 was
reduced in comparison to GM1 especially in the Lo liposomes
(Figure 4). Our data therefore confirm at the molecular level
that the presence of the fluorophore on the acyl chain, rather
than changing the headgroup geometry, largely excludes the
bdGM1 molecules from the Lo membrane environments, where
native GM1 molecules seemed to be enriched (Komura et al.,
2016). Therefore, CTxB binding to GM1 occurs more in the
ordered membranes, while binding to bdGM1 takes place
preferably, if not exclusively, in the disordered domains (Sezgin
et al., 2012b, 2015). The conclusion that the partitioning of
bdGM1 does not properly represent the phase partitioning of
GM1 is consistent with recent findings by Fricke and Dimova
(Fricke and Dimova, 2016) published during the review of this
paper.
Our experiments reveal that the recognition of bdGM1 by
CTxB is decreased in comparison to native GM1 (Figure 4).
Meanwhile, the MD simulations do not suggest strong structural
changes within the headgroup region of the studied GM1
molecules. Therefore, it seems evident that the observed
differences in CTxB recognition do not stem primarily from
differences in headgroup conformation but rather from other
factors such as clustering of GM1 lipids (Shi et al., 2007; Sachl
et al., 2015). Consideration of such dynamical processes based
on slow lateral diffusion through atom-scale MD simulations
remains to be done in future work.
Gangliosides are important receptors at the cell surface, and
the use of fluorescently labeled analogs is a common tool to study
their cellular functions (Ewers et al., 2009; Sachl et al., 2015;
Sezgin et al., 2015; Fricke andDimova, 2016; Komura et al., 2016).
However, the data presented here and in our previous work
(Sezgin et al., 2012b) reveal that the presence of the fluorophore
affects the behavior of the host lipid molecules. We have shown
that acyl-chain labeling of GM1 changes its phase partitioning
without strongly affecting ligand binding (here, CTxB). These
effects should be considered for proper interpretation of cellular
studies employing these and other fluorescent lipid analogs.
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